Florida Eye Microsurgical Institute, Inc. Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00333476
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Florida Eye Microsurgical Institute

Active Ingredients

Drugs in Phase 4 Trials (3)

bromfenac (xibrom) (1 trial)

cyclosporine (sandimmune) (1 trial)

ketorolac (acuvail) (1 trial)

Drugs in Phase 2 Trials (1)

squalamine lactate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Eye Diseases (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Macular Degeneration (Phase 2)

Pterygium (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4